VeriMom¿Es oligopeptide-55 seguro durante el embarazo?
No harmonised CLP classification, no SCCS or CIR safety assessment specific to oligopeptide-55, and no peer-reviewed reproductive or developmental toxicity data located in the sources searched. Peptides of this size are generally polar and have low dermal/systemic bioavailability from topical use, so absent data they are treated as no evidence of reproductive hazard (CIR/SCCS absence). Sources searched: ECHA Annex VI (no listing), SCCS/CIR (no opinion), PubMed (no reproductive studies found), PubChem/CosIng (ingredient present but no toxicity/repro data).
Related ingredients
Frequently asked questions
- ¿Es oligopeptide-55 seguro durante el embarazo?
- No harmonised CLP classification, no SCCS or CIR safety assessment specific to oligopeptide-55, and no peer-reviewed reproductive or developmental toxicity data located in the sources searched. Peptides of this size are generally polar and have low dermal/systemic bioavailability from topical use, so absent data they are treated as no evidence of reproductive hazard (CIR/SCCS absence). Sources searched: ECHA Annex VI (no listing), SCCS/CIR (no opinion), PubMed (no reproductive studies found), PubChem/CosIng (ingredient present but no toxicity/repro data).
- ¿Es oligopeptide-55 seguro durante la lactancia?
- No data indicating lactation transfer or effects on nursing infants. No classifications or published evidence of systemic reproductive/endocrine activity. Given expected low dermal absorption for oligopeptides, systemic exposure to nursing parent is expected to be negligible for typical topical cosmetic use.
- ¿Es oligopeptide-55 seguro para la piel del bebé?
- No evidence of hazard or mechanism specific to infants. Dermal absorption of intact oligopeptides is generally low, but infant skin has immature barrier and higher surface-area-to-weight; therefore exposure (e) is increased by one category relative to adults (adult e=0 → baby e=1) despite no hazard data. No infant-specific studies were found.
- ¿Cómo puntúa VeriMom a oligopeptide-55?
- VeriMom puntúa oligopeptide-55 en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a oligopeptide-55 en el embarazo?
- Consulta nuestra lista de alternativas seguras a oligopeptide-55 según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.